Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: Relevance of interactions between thrombotic material and thrombolytic agent

Vascular Pharmacology

Volumn 43, Issue 4, 2005, Pages 254-259

  Kahles, Timo ^a   Foerch, Christian ^a   Sitzer, Matthias ^a   Schroeter, Michael ^b   Steinmetz, Helmuth ^a   Rami, Abdelhaq ^a   Neumann Haefelin, Tobias ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Blood brain barrier; Cerebral ischemia; MMP 9; Thrombolysis; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; EVANS BLUE; FIBRINOLYTIC AGENT; GELATINASE B; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; EXTRAVASATION; MALE; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; REACTION TIME; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE; THROMBOSIS; THROMBUS; TRANSIENT ISCHEMIC ATTACK; UPREGULATION;

ANIMALS; BASAL GANGLIA; BLOOD-BRAIN BARRIER; BRAIN; EVANS BLUE; FIBRINOLYTIC AGENTS; IMMUNOHISTOCHEMISTRY; ISCHEMIC ATTACK, TRANSIENT; LASER-DOPPLER FLOWMETRY; MALE; MATRIX METALLOPROTEINASE 9; RATS; RATS, WISTAR; REPERFUSION INJURY; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 27744434763     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2005.07.008     Document Type: Article

References (36)

1. P.M. Absher, E. Hendley, D.M. Jaworski, D.J. Taatjes, and B.E. Sobel Impairment of the blood-brain barrier: a potential surrogate delineating the determinants of cerebral bleeding caused by fibrinolytic drugs Coron. Artery Dis. 10 1999 413 420
2. T. Aoki, T. Sumii, T. Mori, X. Wang, and E.H. Lo Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats Stroke 33 2002 2711 2717
3. M. Asahi, K. Asahi, J.C. Jung, G.J. del Zoppo, M.E. Fini, and E.H. Lo Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94 J. Cereb. Blood Flow Metab. 20 2000 1681 1689
4. M. Asahi, X. Wang, T. Mori, T. Sumii, J.C. Jung, M.A. Moskowitz, M.E. Fini, and E.H. Lo Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia J. Neurosci. 21 2001 7724 7732
5. M.P. Bowes, J.A. Zivin, G.R. Thomas, H. Thibodeaux, and S.C. Fagan Acute hypertension, but not thrombolysis, increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbits Exp. Neurol. 141 1996 40 46
6. E. Busch, K. Kruger, and K.A. Hossmann Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat Brain Res. 778 1997 16 24
7. Z.L. Chen, and S. Strickland Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin Cell 91 1997 917 925
8. D. Collen The plasminogen (fibrinolytic) system Thromb. Haemost. 82 1999 259 270
9. G.J. del Zoppo, and T. Mabuchi Cerebral microvessel responses to focal ischemia J. Cereb. Blood Flow Metab. 23 2003 879 894
10. A.M. Demchuk, L.B. Morgenstern, D.W. Krieger, Chi T. Linda, W. Hu, T.H. Wein, R.J. Hardy, J.C. Grotta, and A.M. Buchan Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke Stroke 30 1999 34 39
11. M. Fujimura, Y. Gasche, Y. Morita-Fujimura, J. Massengale, M. Kawase, and P.H. Chan Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion Brain Res. 842 1999 92 100
12. S. Fukuda, C.A. Fini, T. Mabuchi, J.A. Koziol, L.L. Eggleston Jr., and G.J. Del Zoppo Focal cerebral ischemia induces active proteases that degrade microvascular matrix Stroke 35 2004 998 1004
13. S. Gautier, O. Petrault, P. Gele, M. Laprais, M. Bastide, A. Bauters, D. Deplanque, B. Jude, J. Caron, and R. Bordet Involvement of thrombolysis in recombinant tissue plasminogen activator-induced cerebral hemorrhages and effect on infarct volume and postischemic endothelial function Stroke 34 2003 2975 2979
14. G.F. Hamann, Y. Okada, R. Fitridge, and G.J. del Zoppo Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion Stroke 26 1995 2120 2126
15. J. Kaur, Z. Zhao, G.M. Klein, E.H. Lo, and A.M. Buchan The neurotoxicity of tissue plasminogen activator? J. Cereb. Blood Flow Metab. 24 2004 945 963
16. E. Kilic, D.M. Hermann, and K.A. Hossmann Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice NeuRoreport 10 1999 107 111
17. G.M. Klein, H. Li, P. Sun, and A.M. Buchan Tissue plasminogen activator does not increase neuronal damage in rat models of global and focal ischemia Neurology 52 1999 1381 1384
18. C. Korninger, and D. Collen Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro Thromb. Haemost. 46 1981 561 565
19. T. Kuroiwa, P. Ting, H. Martinez, and I. Klatzo The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion Acta Neuropathol. (Berl.) 68 1985 122 129
20. S.R. Lee, K. Tsuji, and E.H. Lo Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia J. Neurosci. 24 2004 671 678
21. W. Meng, X. Wang, M. Asahi, T. Kano, K. Asahi, R.H. Ackerman, and E.H. Lo Effects of tissue type plasminogen activator in embolic versus mechanical models of focal cerebral ischemia in rats J. Cereb. Blood Flow Metab. 19 1999 1316 1321
22. J.E. Meredith Jr., B. Fazeli, and M.A. Schwartz The extracellular matrix as a cell survival factor Mol. Biol. Cell 4 1993 953 961
23. Z. Nagy, K. Kolev, E. Csonka, M. Vastag, and R. Machovich Perturbation of the integrity of the blood-brain barrier by fibrinolytic enzymes Blood Coagul. Fibrinolysis 9 1998 471 478
24. T. Neumann-Haefelin, A. Kastrup, A. de Crespigny, M.A. Yenari, T. Ringer, G.H. Sun, and M.E. Moseley Serial MRI after transient focal cerebral ischemia in rats: dynamics of tissue injury, blood-brain barrier damage, and edema formation Stroke 31 2000 1965 1972 (discussion 1972-1963)
25. K. Overgaard, T. Sereghy, G. Boysen, H. Pedersen, and N.H. Diemer Reduction of infarct volume and mortality by thrombolysis in a rat embolic stroke model Stroke 23 1992 1167 1173 (discussion 1174)
26. T. Pfefferkorn, and G.A. Rosenberg Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion Stroke 34 2003 2025 2030
27. G.A. Rosenberg, M. Navratil, F. Barone, and G. Feuerstein Proteolytic cascade enzymes increase in focal cerebral ischemia in rat J. Cereb. Blood Flow Metab. 16 1996 360 366
28. M.L. Simoons, A.P. Maggioni, G. Knatterud, J.D. Leimberger, P. de Jaegere, R. van Domburg, E. Boersma, M.G. Franzosi, R. Califf, and R. Schroder Individual risk assessment for intracranial haemorrhage during thrombolytic therapy Lancet 342 1993 1523 1528
29. T. Sumii, and E.H. Lo Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats Stroke 33 2002 831 836
30. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N. Engl. J. Med. 333 1995 1581 1587
31. O. Uyama, N. Okamura, M. Yanase, M. Narita, K. Kawabata, and M. Sugita Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence J. Cereb. Blood Flow Metab. 8 1988 282 284
32. S. Wagner, and G.F. Hamann Experimental microvascular and clotting changes - significance for acute stroke therapy Nervenarzt 74 2003 123 132
33. S. Wagner, M. Tagaya, J.A. Koziol, V. Quaranta, and G.J. del Zoppo Rapid disruption of an astrocyte interaction with the extracellular matrix mediated by integrin alpha 6 beta 4 during focal cerebral ischemia/reperfusion Stroke 28 1997 858 865
34. Y.F. Wang, S.E. Tsirka, S. Strickland, P.E. Stieg, S.G. Soriano, and S.A. Lipton Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice Nat. Med. 4 1998 228 231
35. X. Wang, S.R. Lee, K. Arai, K. Tsuji, G.W. Rebeck, and E.H. Lo Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator Nat. Med. 9 2003 1313 1317
36. M. Yepes, M. Sandkvist, E.G. Moore, T.H. Bugge, D.K. Strickland, and D.A. Lawrence Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein J. Clin. Invest. 112 2003 1533 1540